Aridis pharmaceuticals announces proposed public offering of common stock

Los gatos, calif. , sept. 26, 2022 /prnewswire/ -- aridis pharmaceuticals, inc. (nasdaq: ards), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, today announced that it intends to offer its common stock in a public offering.
ARDS Ratings Summary
ARDS Quant Ranking